Genome-wide association study of interferon-related cytopenia in chronic hepatitis C patients.

Détails

ID Serval
serval:BIB_A440EE63322F
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
Genome-wide association study of interferon-related cytopenia in chronic hepatitis C patients.
Périodique
Journal of Hepatology
Auteur(s)
Thompson A.J., Clark P.J., Singh A., Ge D., Fellay J., Zhu M., Zhu Q., Urban T.J., Patel K., Tillmann H.L., Naggie S., Afdhal N.H., Jacobson I.M., Esteban R., Poordad F., Lawitz E.J., McCone J., Shiffman M.L., Galler G.W., King J.W., Kwo P.Y., Shianna K.V., Noviello S., Pedicone L.D., Brass C.A., Albrecht J.K., Sulkowski M.S., Goldstein D.B., McHutchison J.G., Muir A.J.
ISSN
1600-0641 (Electronic)
ISSN-L
0168-8278
Statut éditorial
Publié
Date de publication
2012
Volume
56
Numéro
2
Pages
313-319
Langue
anglais
Notes
Publication types: Journal Article ; Research Support, Non-U.S. Gov'tPublication Status: ppublish
Résumé
BACKGROUND & AIMS: Interferon-alfa (IFN)-related cytopenias are common and may be dose-limiting. We performed a genome wide association study on a well-characterized genotype 1 HCV cohort to identify genetic determinants of peginterferon-α (pegIFN)-related thrombocytopenia, neutropenia, and leukopenia.
METHODS: 1604/3070 patients in the IDEAL study consented to genetic testing. Trial inclusion criteria included a platelet (Pl) count ≥80×10(9)/L and an absolute neutrophil count (ANC) ≥1500/mm(3). Samples were genotyped using the Illumina Human610-quad BeadChip. The primary analyses focused on the genetic determinants of quantitative change in cell counts (Pl, ANC, lymphocytes, monocytes, eosinophils, and basophils) at week 4 in patients >80% adherent to therapy (n=1294).
RESULTS: 6 SNPs on chromosome 20 were positively associated with Pl reduction (top SNP rs965469, p=10(-10)). These tag SNPs are in high linkage disequilibrium with 2 functional variants in the ITPA gene, rs1127354 and rs7270101, that cause ITPase deficiency and protect against ribavirin (RBV)-induced hemolytic anemia (HA). rs1127354 and rs7270101 showed strong independent associations with Pl reduction (p=10(-12), p=10(-7)) and entirely explained the genome-wide significant associations. We believe this is an example of an indirect genetic association due to a reactive thrombocytosis to RBV-induced anemia: Hb decline was inversely correlated with Pl reduction (r=-0.28, p=10(-17)) and Hb change largely attenuated the association between the ITPA variants and Pl reduction in regression models. No common genetic variants were associated with pegIFN-induced neutropenia or leucopenia.
CONCLUSIONS: Two ITPA variants were associated with thrombocytopenia; this was largely explained by a thrombocytotic response to RBV-induced HA attenuating IFN-related thrombocytopenia. No genetic determinants of pegIFN-induced neutropenia were identified.
Mots-clé
Adult, Antiviral Agents/adverse effects, Female, Genome-Wide Association Study, Hepatitis C, Chronic/drug therapy, Hepatitis C, Chronic/genetics, Humans, Interferon-alpha/adverse effects, Leukopenia/chemically induced, Leukopenia/genetics, Linkage Disequilibrium, Male, Middle Aged, Neutropenia/chemically induced, Neutropenia/genetics, Polyethylene Glycols/adverse effects, Polymorphism, Single Nucleotide, Pyrophosphatases/genetics, Recombinant Proteins/adverse effects, Ribavirin/adverse effects, Thrombocytopenia/chemically induced, Thrombocytopenia/genetics
Pubmed
Web of science
Création de la notice
10/04/2013 14:59
Dernière modification de la notice
20/08/2019 16:09
Données d'usage